BioMarin Pharmaceutical, Inc. (BMRN)
62.62
-0.30
(-0.48%)
USD |
NASDAQ |
Feb 24, 16:00
61.69
-0.93
(-1.49%)
After-Hours: 04:54
BioMarin Pharmaceutical Total Liabilities (Quarterly) : 1.507B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 675.63M |
| Gilead Sciences, Inc. | 36.40B |
| Merck & Co., Inc. | -- |
| AbbVie, Inc. | 137.19B |
| Bristol Myers Squibb Co. | 71.53B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.594B |
| Shareholders Equity (Quarterly) | 6.087B |
| Debt to Equity Ratio | 0.0981 |
| Current Ratio | 5.209 |
| Net Debt Paydown Yield | 0.02% |